HARVARD BIOSCIENCES –

Holliston, Mass.

Went public 12/07/00 at $8 per share.

Filing Range: 6.42 million shares @ $9 to $10

Shares Outstanding: 24.78 million shares

Underwriters: Thomas Weisel Partners LLC/Dain Rauscher

Wessels/ING Barings

Company Counsel: Goodwin Procter & Hoar

Manager Counsel: Mintz Levin Cohn Ferris Glovsky & Popeo

Auditor: KPMG LLP

The Company:

Distributes and sells medical devices through catalogs and the Internet. The company’s products include volume and pressure controlled ventilators, pulsatile blood pumps, transducers, amplifiers, recorders, glassware and many other specialized bioscience research products.

Venture Backers:

New England Partners

Ascent Venture Partners

First New England Capital LP

Financing Rounds

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 03/01/1996 2 Early Stage 990.0

2 05/11/1999 2 Expansion 1038.0

Financials:

(Data in $ millions)

Y/E

12/31/99

Total Revenues: $26.2

Net Income: (29.4)